Treatment of protein degradation disorders

Details for Australian Patent Application No. 2006226861 (hide)

Owner President and Fellows of Harvard College Dana-Farber Cancer Institute, Inc.

Inventors Shaw, Jared; Mazitschek, Ralph; Bradner, James Elliott; Hideshima, Teru; Kwiatkowski, Nicholas Paul; Schreiber, Stuart L.; Anderson, Kenneth C.; Greenberg, Edward Franklin; Haggarty, Stephen J.

Agent Davies Collison Cave

Pub. Number AU-B-2006226861

PCT Pub. Number WO2006/102557

Priority 60/664,470 22.03.05 US

Filing date 22 March 2006

Wipo publication date 28 September 2006

Acceptance publication date 16 August 2012

International Classifications

A61K 31/42 - Oxazoles

A61K 31/335 - having oxygen as the only ring hetero atom, e.g. fungichromin

Event Publications

11 October 2007 PCT application entered the National Phase

  PCT publication WO2006/102557 Priority application(s): WO2006/102557

2 October 2008 Alteration of Name

  The name of the applicant has been altered to Dana-Farber Cancer Institute, Inc.; President and Fellows of Harvard College Amendments

16 August 2012 Application Accepted

  Published as AU-B-2006226861

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006226863-Drought-resistant plants

2006226849-Personal protection system for fitting over a head and a neck